When would you offer post-operative concurrent chemoradiation in anaplastic thyroid cancer?
Would you consider it for a patient with good PS but with limited metastatic disease? What dose fractionation would you prefer?
Answer from: Radiation Oncologist at Academic Institution
The management of ATC has evolved considerably over recent years with the most significant being a dichotomy of management based on Braf mutation.
We typically offer postoperative XRT, including in patients with either a limited or stable DM disease. However, in a multidisciplinary setting, there s...
Sign in or Register to read more